Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | 199,381 | reported | 02 Mar 2026 | tx 114+889,965−149,363 |
| Chromocell Therapeutics Corp | 58,230 | reported | 02 Jul 2025 | tx 9+1,816,365.68−15,000 |
| Vaxart, Inc. | 44,224 | reported | 04 Aug 2022 | tx 8+241,836−61,470 |
| PALVELLA THERAPEUTICS, INC. | 12,350 | reported | 10 Jun 2025 | tx 2+37,050 |
| ARTES MEDICAL INC | 6,250 | reported | 13 Feb 2008 | tx 5+2,993,750 |
| BIODELIVERY SCIENCES INTERNATIONAL INC | 0 | reported | 22 Mar 2022 | tx 23+751,097−751,172 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 10,495 | 0.00 USD | |
| 02 Mar 2026 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 50,058 | 0.00 USD | deriv |
| 15 Feb 2026 | TAX_WITHHOLDING | LIGAND PHARMACEUTICALS INC | 2,039 | 183.83 USD | |
| 15 Feb 2026 | TAX_WITHHOLDING | LIGAND PHARMACEUTICALS INC | 4,255 | 183.83 USD | |
| 15 Feb 2026 | TAX_WITHHOLDING | LIGAND PHARMACEUTICALS INC | 2,805 | 183.83 USD | |
| 14 Feb 2026 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 39,644 | 0.00 USD | |
| 14 Feb 2026 | TAX_WITHHOLDING | LIGAND PHARMACEUTICALS INC | 8,178 | 183.83 USD | |
| 14 Feb 2026 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 20,782 | 0.00 USD | |
| 14 Feb 2026 | TAX_WITHHOLDING | LIGAND PHARMACEUTICALS INC | 15,600 | 183.83 USD | |
| 04 Dec 2025 | GIFT | LIGAND PHARMACEUTICALS INC | 130 | 0.00 USD | |
| 02 Jul 2025 | GRANT_AWARD | Chromocell Therapeutics Corp | 19,108 | — | deriv |
| 02 Jul 2025 | GRANT_AWARD | Chromocell Therapeutics Corp | 58,230 | — | deriv |
| 01 Jul 2025 | CONVERSION | Chromocell Therapeutics Corp | 1,500,000 | 10.00 USD | |
| 01 Jul 2025 | CONVERSION | Chromocell Therapeutics Corp | 15,000 | 0.00 USD | deriv |
| 01 Jul 2025 | OTHER | Chromocell Therapeutics Corp | 31,278.68 | — | deriv |
| 30 Jun 2025 | OTHER | LIGAND PHARMACEUTICALS INC | 233 | 91.08 USD | |
| 10 Jun 2025 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 12,350 | 0.00 USD | deriv |
| 09 May 2025 | PURCHASE | LIGAND PHARMACEUTICALS INC | 1,680 | 104.57 USD | |
| 09 May 2025 | PURCHASE | LIGAND PHARMACEUTICALS INC | 2,307 | 104.53 USD | |
| 09 May 2025 | PURCHASE | LIGAND PHARMACEUTICALS INC | 5,523 | 105.67 USD | |
| 04 Mar 2025 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 21,382 | 0.00 USD | |
| 04 Mar 2025 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 93,476 | 0.00 USD | deriv |
| 15 Feb 2025 | TAX_WITHHOLDING | LIGAND PHARMACEUTICALS INC | 2,231 | 120.00 USD | |
| 14 Feb 2025 | TAX_WITHHOLDING | LIGAND PHARMACEUTICALS INC | 6,966 | 120.00 USD | |
| 15 Feb 2025 | TAX_WITHHOLDING | LIGAND PHARMACEUTICALS INC | 4,255 | 120.00 USD |
3 purchases reported after at least 12 months of silence — most recent on 22 Sept 2023.